Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease

Hepatology

Volumn 57, Issue 2, 2013, Pages 505-514

  Vazquez Chantada, Mercedes ^a,b   Gonzalez Lahera, Aintzane ^a   Martinez Arranz, Ibon ^b   Garcia Monzon, Carmelo ^c   Regueiro, Manuela M ^a,d   Garcia Rodriguez, Juan L ^a   Schlangen, Karin A ^a,e   Mendibil, Iñaki ^a   Rodriguez Ezpeleta, Naiara ^a,f   Lozano, Juan J ^g   Banasik, Karina ^h   Justesen, Johanne M ^h   Joergensen, Torben ^i,j   Witte, Daniel R ^k   Lauritzen, Torsten ^l   Hansen, Torben ^h,m,n   Pedersen, Oluf ^h,j,m,o   Veyrie, Nicolas ^p,q,x   Clement, Karine ^q,r,s,x   Tordjman, Joan ^q,r,x   Tran, Albert ^t   Le Marchand Brustel, Yannik ^t   Buque, Xabier ^u   Aspichueta, Patricia ^u   Echevarria Uraga, Jose J ^v   Martin Duce, Antonio ^w   Caballeria, Joan ^a   Gual, Philippe ^t   Castro, Azucena ^b   Mato, Jose M ^a   Martinez Chantar, Maria L ^a   Aransay, Ana M ^a   more..

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b OWL Genomics   (Spain)

^c HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^e MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^f MARINE RESEARCH DIVISION   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h Capital Region   (Denmark)

ⁱ GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k STENO DIABETES CENTER   (Denmark)

^l AARHUS UNIVERSITY   (Denmark)

^m HAGEDORN RESEARCH INSTITUTE   (Denmark)

ⁿ UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^o AARHUS UNIVERSITY   (Denmark)

^p LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^q CENTRE DE RECHERCHE DES CORDELIERS   (France)

^r PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^s CENTRE MAURICE HALBWACHS   (France)

^t INSERM   (France)

^u UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^v HOSPITAL DE GALDAKAO   (Spain)

^w UNIVERSITY OF ALCALÁ   (Spain)

^x SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBODIPYRIMIDINE PHOTOLYASE; GLUCOSE TRANSPORTER 1; HYDROETHIDINE; LIPID; OLEIC ACID; TRANSCRIPTOME; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE SEQUENCE; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; LIVER; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; GENE FREQUENCY; GENE SILENCING; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MALE; MIDDLE AGED; OLEIC ACID; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTOME;

EID: 84873282538     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26052     Document Type: Article

References (46)

1. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-285.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
3. Brunt EM. Nonalcoholic steatohepatitis (NASH): further expansion of this clinical entity? Liver 1999; 19: 263-264.
4. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol 2004; 2: 1048-1058.
5. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-1465.
6. Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011; 7: e1001324.
7. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474.
8. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. HEPATOLOGY 2005; 41: 1313-1321.
9. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 2003; 10: 377-386.
10. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000; 24(Suppl 3): S6-S11.
11. Barr J, Vazquez-Chantada M, Alonso C, Perez-Cormenzana M, Mayo R, Galan A, et al. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J Proteome Res 2010; 9: 4501-4512.
12. Rodriguez-Suarez E, Duce AM, Caballeria J, Martinez Arrieta F, Fernandez E, Gomara C, et al. Non-alcoholic fatty liver disease proteomics. Proteomics Clin Appl 2010; 4: 362-371.
13. Rubio A, Guruceaga E, Vazquez-Chantada M, Sandoval J, Martinez-Cruz LA, Segura V, et al. Identification of a gene-pathway associated with non-alcoholic steatohepatitis. J Hepatol 2007; 46: 708-718.
14. Mato JM, Martinez-Chantar ML, Lu SC. Methionine metabolism and liver disease. Annu Rev Nutr 2008; 28: 273-293.
15. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J Biol Chem 1984; 259: 9508-9513.
16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
17. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
18. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
19. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001; 25: 386-401.
20. Pfeifer AM, Cole KE, Smoot DT, Weston A, Groopman JD, Shields PG, et al. Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc Natl Acad Sci U S A 1993; 90: 5123-5127.
21. Martinez-Lopez N, Varela-Rey M, Fernandez-Ramos D, Woodhoo A, Vazquez-Chantada M, Embade N, et al. Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis. HEPATOLOGY 2010; 52: 1621-1631.
22. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547-1548.
23. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29.
24. Al-Shahrour F, Arbiza L, Dopazo H, Huerta-Cepas J, Minguez P, Montaner D, Dopazo J. From genes to functional classes in the study of biological systems. BMC Bioinformatics 2007; 8: 114.
25. Fath MA, Diers AR, Aykin-Burns N, Simons AL, Hua L, Spitz DR. Mitochondrial electron transport chain blockers enhance 2-deoxy-D-glucose induced oxidative stress and cell killing in human colon carcinoma cells. Cancer Biol Ther 2009; 8: 1228-1236.
26. Kessler RJ, Fanestil DD. Interference by lipids in the determination of protein using bicinchoninic acid. Anal Biochem 1986; 159: 138-142.
27. Baylin A, Kabagambe EK, Siles X, Campos H. Adipose tissue biomarkers of fatty acid intake. Am J Clin Nutr 2002; 76: 750-757.
28. Xu M, Wang W, Frontera JR, Neely MC, Lu J, Aires D, et al. Ncb5or deficiency increases fatty acid catabolism and oxidative stress. J Biol Chem 2011; 286: 11141-11154.
29. Redden DT, Allison DB. Nonreplication in genetic association studies of obesity and diabetes research. J Nutr 2003; 133: 3323-3326.
30. Wang K, Li WD, Zhang CK, Wang Z, Glessner JT, Grant SF, et al. A genome-wide association study on obesity and obesity-related traits. PLoS One 2011; 6: e18939.
31. Noshiro M, Usui E, Kawamoto T, Sato F, Nakashima A, Ueshima T, et al. Liver X receptors (LXRalpha and LXRbeta) are potent regulators for hepatic Dec1 expression. Genes Cells 2009; 14: 29-40.
32. Gokey NG, Lopez-Anido C, Gillian-Daniel AL, Svaren J. Early growth response 1 (Egr1) regulates cholesterol biosynthetic gene expression. J Biol Chem 2011; 286: 29501-29510.
33. Barbato A, Iacone R, Tarantino G, Russo O, Sorrentino P, Avallone S, et al. Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy. Intern Emerg Med 2009; 4: 315-323.
34. Hora C, Negro F, Leandro G, Oneta CM, Rubbia-Brandt L, Muellhaupt B, et al. Connective tissue growth factor, steatosis, and fibrosis in patients with chronic hepatitis C. Liver Int 2008; 28: 370-376.
35. Jones KT, Greer ER, Pearce D, Ashrafi K. Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1. PLoS Biol 2009; 7: e60.
36. Poynard T, Ratziu V, McHutchison J, Manns M, Goodman Z, Zeuzem S, et al. Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C. HEPATOLOGY 2003; 38: 75-85.
37. Younossi ZM, Afendy A, Stepanova M, Hossain N, Younossi I, Ankrah K, et al. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C. Liver Int 2009; 29: 1403-1412.
38. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
39. Kc S, Carcamo JM, Golde DW. Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J 2005; 19: 1657-1667.
40. Serviddio G, Bellanti F, Vendemiale G, Altomare E. Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 2011; 5: 233-244.
41. Bilir BM, Gong TW, Kwasiborski V, Shen CS, Fillmore CS, Berkowitz CM, Gumucio JJ. Novel control of the position-dependent expression of genes in hepatocytes. The GLUT-1 transporter. J Biol Chem 1993; 268: 19776-19784.
42. Rhoads DB. Liver GLUT-1 expression: an enigma deepens. HEPATOLOGY 1994; 19: 540-542.
43. Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16: 5286-5296.
44. Lutoslawska G. Interrelationship between carbohydrate and lipid metabolism (glucose-fatty acid cycle). Medicina Sportiva 2002; 6: E115-E131.
45. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998; 14: 263-283.
46. Anderson N, Borlak J. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev 2008; 60: 311-357.